Transmission of Human Herpesvirus Type 8 Infection Within Families in American Indigenous Populations From the Brazilian Amazon

Imagem de Miniatura
Arquivos
art_FREIRE_Transmission_of_Human_Herpesvirus_Type_8_Infection_Within_2012.PDF (123.18 KB)
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS INC
Autores
GIAMBARTOLOMEI, Claudia
DUDBRIDGE, Frank
GREGORIO, Shinai Arriel
QUIROGA, Mariana
MAYAUD, Philippe
Citação
JOURNAL OF INFECTIOUS DISEASES, v.205, n.12, p.1869-1876, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. The intrafamilial dynamics of endemic infection with human herpesvirus type 8 (HHV-8) in Amerindian populations is unknown. Methods. Serum samples were obtained from 517 Amerindians and tested for HHV-8 anti-latent nuclear antigen (anti-LANA) and antilytic antibodies by immunofluorescence assays. Logistic regression and mixed logistic models were used to estimate the odds of being HHV-8 seropositive among intrafamilial pairs. Results. HHV-8 seroprevalence by either assay was 75.4% (95% confidence interval [CI]: 71.5%-79.1%), and it was age-dependent (P-trend<.001). Familial dependence in HHV-8 seroprevalence by either assay was found between mother-offspring (odds ratio [OR], 5.44; 95% CI: 1.62-18.28) and siblings aged >= 10 years (OR 4.42, 95% CI: 1.70-11.45) or siblings in close age range (<5 years difference) (OR 3.37, 95% CI: 1.21-9.40), or in families with large (>4) number of siblings (OR, 3.20, 95% CI: 1.33-7.67). In separate analyses by serological assay, there was strong dependence in mother-offspring (OR 8.94, 95% CI: 2.94-27.23) and sibling pairs aged >= 10 years (OR, 11.91, 95% CI: 2.23-63.64) measured by LANA but not lytic antibodies. Conclusions. This pattern of familial dependence suggests that, in this endemic population, HHV-8 transmission mainly occurs from mother to offspring and between close siblings during early childhood, probably via saliva. The mother to offspring dependence was derived chiefly from anti-LANA antibodies.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/723
Referências
  1. Alkharsah KR, 2007, J INFECT DIS, V195, P809, DOI 10.1086/511827
  2. Biggar RJ, 2000, J INFECT DIS, V181, P1562, DOI 10.1086/315456
  3. Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453
  4. Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a
  5. Butler LM, 2011, J INFECT DIS, V203, P625, DOI 10.1093/infdis/jiq092
  6. Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621
  7. Cassar O, 2010, EMERG INFECT DIS, V16, P1459, DOI 10.3201/eid1609.100381
  8. Caterino-de-Araujo A, 2010, J MED VIROL, V82, P1576, DOI 10.1002/jmv.21854
  9. CESARMAN E, 1995, BLOOD, V86, P2708
  10. CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
  11. Cunha AMG, 2005, J GEN VIROL, V86, P2433, DOI 10.1099/vir.0.81087-0
  12. Davidovici B, 2001, J NATL CANCER I, V93, P194, DOI 10.1093/jnci/93.3.194
  13. Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.660745
  14. Dedicoat M, 2004, J INFECT DIS, V190, P1068, DOI 10.1086/423326
  15. de Souza VAUF, 2007, J INFECT DIS, V196, P844, DOI 10.1086/520549
  16. Dupin N, 2000, BLOOD, V95, P1406
  17. Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567
  18. Grossman Z, 2002, MAYO CLIN PROC, V77, P905
  19. Guech-Ongey Mercy, 2010, Infect Agent Cancer, V5, P21, DOI 10.1186/1750-9378-5-21
  20. Hudnall SD, 2003, TRANSFUSION, V43, P85, DOI 10.1046/j.1537-2995.2003.00272.x
  21. Kazanji M, 2005, J INFECT DIS, V192, P1525, DOI 10.1086/491744
  22. Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132
  23. Malope BI, 2008, AIDS, V22, P519, DOI 10.1097/QAD.0b013e3282f46582
  24. Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403
  25. Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6<817::AID-IJC2>3.0.CO;2-X
  26. Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973
  27. Mohanna S, 2006, AM J TROP MED HYG, V75, P324
  28. Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06
  29. Plancoulaine S, 2003, J INFECT DIS, V187, P1944, DOI 10.1086/375345
  30. Plancoulaine S, 2004, CANCER RES, V64, P8782, DOI 10.1158/0008-5472.CAN-04-2000
  31. Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X
  32. SOULIER J, 1995, BLOOD, V86, P1276
  33. Souza VAUF, 2010, EMERG INFECT DIS, V16, P1003, DOI 10.3201/eid1606.090961
  34. StataCorp, 2003, STAT STAT SOFTW REL
  35. Tedeschi R, 2006, J MED VIROL, V78, P372, DOI 10.1002/jmv.20549
  36. Whitby D, 2004, J GEN VIROL, V85, P155, DOI 10.1099/vir.0.19465-0
  37. Wojcicki JM, 2003, BRIT J CANCER, V89, P2016, DOI 10.1038/sj.bjc.6601390

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/52